Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6

Acta Biochimica et Biophysica Sinica

Volumn 38, Issue 10, 2006, Pages 683-690

  Fan, Xiong Lin ^a   Yu, Ting He ^b   Gao, Qian ^a   Yao, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bacillus Calmette Gu rin (BCG); Early secreted antigenic target 6 kDa (ESAT 6); Interleukin (IL) 2; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; HYBRID PROTEIN; INTERLEUKIN 2;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; MYCOBACTERIUM BOVIS; TH1 CELL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; RECOMBINANT FUSION PROTEINS; TH1 CELLS;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 33750439854     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2006.00217.x     Document Type: Article

References (31)

1. Fine PE. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 1995, 346: 1339-1345
2. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S. Recombinant bacillus calmette-guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000, 97: 13853-13858
3. Dhar N, Rao V, Tyagi AK. Recombinant BCG approach for development of vaccines: Cloning and expression of immunodominant antigens of M. tuberculosis. FEMS Microbiol Lett 2000, 190: 309-316
4. Castanon-Arreola M, Lopez-Vidal Y, Espitia-Pinzon C, Hernandez-Pando R. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Tuberculosis 2005, 85: 115-126
5. Yeremeev VV, Stewart GR, Neyrolles O, Skrabal K, Avdienko VG, Apt AS, Young DB. Deletion of the 19 kDa antigen does not alter the protective efficacy of BCG. Tuber Lung Dis 2000, 80: 243-247
6. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9: 533-539
7. Bao L, Chen W, Zhang H, Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003, 71: 1656-1661
8. Shi CH, Fan XL, Shi JR, Xu ZK, Li Y, Bai YN, Xun Y. Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium. Zhonghua Jie He He Hu Xi Za Zhi 2004, 27: 249-252
9. O'Donnell MA, Aldovini A, Duda RB, Yang H, Szilvasi A, Young RA, DeWolf WC. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 1994, 62: 2508-2514
10. Murray PJ, Aldovini A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 1996, 93: 934-939
11. Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Infect Immun 2002, 70: 6549-6557
12. Wangoo A, Brown IN, Marshall BG, Cook HT, Young DB, Shaw RJ. Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: Modulation by recombinant BCG expressing interferon-γ (IFN-.γ). Clin Exp Immunol 2000, 119: 92-98
13. Jeevan A, Asherson GL. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice. Infect Immun 1988, 56: 660-664
14. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284: 1520-1523
15. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995, 63: 1491-1497
16. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995, 154: 3359-3372
17. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 2000, 68: 791-795
18. Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 1999, 67: 1702-1707
19. Mollenkopf HJ, Groine-Triebkorn D, Andersen P, Hess J, Kaufmann SH. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 2001, 19: 4028-4035
20. Fan XL, Wang LM, Lu XY, Tu ZG, Shi CH, Xu ZK. Cloning and expression of the fusion protein of interleukin-2 and ESAT6 in Mycobacterium bovis Bacillus Calmette-Guérin strain. Chin Med J (Engl) 2005, 118: 762-765
21. Gaora P. Expression of genes in Mycobacteria. In: Parish T, Stoker NG eds. Mycobacteria Protocols. New Jersey: Humana Press 1998
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63
23. Duan Y, Li Y, Li BH, Bai YL, Xue Y, Fan XL, XU ZK. Cloning and expression of ESAT-6 of Mycobacterium tuberculosis H37Rv and IFN-γ production of human T lymphocytes stimulated by ESAT-6 protein. Zhong Hua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi 2003, 23: 62
24. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19: 93-129
25. Orme IM. Immunity to mycobacteria. Curr Opin Immunol 1993, 5: 497-502
26. Henney CS, Kuribayashi K, Kern DE, Gillis S. Interleukin-2 augments natural killer cell activity. Nature 1981, 291: 335-338
27. Kjeldsen-Kragh J, Quayle AJ, Skalhegg BS, Sioud M, Forre O. Selective activation of resting human gamma delta T lymphocytes by interleukin-2. Eur J Immunol 1993, 23: 2092-2099
28. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001, 1: 20-30
29. Fine PEM, Carneiro IAM, Milstien JB, Clements CJ. Issues relating to the use of BCG in immunization programmes. World Health Organization, Geneva, 1999, 18-20
30. Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996, 157: 3527-3533
31. + T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998, 95: 270-275